Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ULTRALIFE CORPULBI · Entity 6735 | Director · Director, President and CEO | December 17, 2021 | December 21, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ULTRALIFE CORP
Report date December 17, 2021 · Filed December 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock; $.10 par valueSEC Table I · non-derivative | Direct | 316,509 |
Reported balance
After 2021-12-17 transaction · row 1
1 source rowRow 1 · 2021-12-17 · Exercise / conversion · Acquired 6,583 · Balance 316,509 F1: Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,417 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long-Term Incentive Plan in payment of the exercise price for the options. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $3.79 · Expires 2022-03-05 | Direct | 0 |
Reported balance
After 2021-12-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-17 · Exercise / conversion · Disposed 20,000 · Balance 0 F2: Represents exercise of options for 20,000 shares of common stock of the Company otherwise expiring on 3/5/2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,417 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long-Term Incentive Plan in payment of the exercise price for the options.
F2: Represents exercise of options for 20,000 shares of common stock of the Company otherwise expiring on 3/5/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2021 Filed Dec 21, 2021 13:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionStock Options · Derivative | 20,000 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001437749-21-029015 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents exercise of options for 20,000 shares of common stock of the Company otherwise expiring on 3/5/2022. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 13:54 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionCommon Stock; $.10 par value | 6,583 | $3.79 | $24,933.77 |
DisclosureSEC source: 0001437749-21-029015 · rdgdoc.xml · nonDerivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,417 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long-Term Incentive Plan in payment of the exercise price for the options. Read SEC document |
| October 20, 2021 Filed Oct 22, 2021 15:06 UTC | ULTRALIFE CORP ULBI · Entity 6735 | GrantCommon Stock (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $6.97 | $0.00 |
DisclosureSEC source: 0001437749-21-024122 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-10-20 F1 · derivative.exercise_date: These options vest as follows: 13,334 shares on 10-20-2022; 13,333 shares vest on 10-20-2023 and 13,333 shares vest on 10-20-2024. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 15:10 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionStock Options · Derivative | 40,000 | $0.00 Strike: $3.71 | $0.00 |
DisclosureSEC source: 0001437749-21-019587 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: (2) Represents exercise of options for 40,000 shares of common stock of the Company otherwise expiring on 3/3/2022. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 15:10 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionCommon Stock; $.10 par value | 12,709 | $3.71 | $47,154.20 |
DisclosureSEC source: 0001437749-21-019587 · rdgdoc.xml · nonDerivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 40,000 shares of common stock of the Company, net of 27,291 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan in payment of the exercise price for the options and the Reporting Person's individual tax withholdings. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:04 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionStock Options · Derivative | 300,000 | $0.00 Strike: $6.42 | $0.00 |
DisclosureSEC source: 0001437749-20-024388 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 300,000 shares Expires 2020-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: (2) Represents exercise of options for 300,000 shares of common stock of the Company otherwise expiring on 12/30/2020. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:04 UTC | ULTRALIFE CORP ULBI · Entity 6735 | Exercise / conversionCommon Stock; $.10 par value | 26,929 | $6.42 | $172,932.65 |
DisclosureSEC source: 0001437749-20-024388 · rdgdoc.xml · nonDerivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 300,000 shares of common stock of the Company, net of 273,071 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2004 Long Term Incentive Plan in payment of the exercise price for the options and the Reporting Person's individual minimum statutory withholding tax obligation. Read SEC document |
| April 22, 2020 Filed Apr 23, 2020 18:52 UTC | ULTRALIFE CORP ULBI · Entity 6735 | GrantCommon Stock (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001437749-20-008325 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-04-22 F1 · derivative.exercise_date: These options vest as follows: 13,334 shares on 04-22-2021; 13,333 shares on 04-22-2022 and 13,333 shares on 04-22-2023. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 20:02 UTC | ULTRALIFE CORP ULBI · Entity 6735 | GrantCommon Stock (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $8.25 | $0.00 |
DisclosureSEC source: 0001437749-19-014661 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2026-07-23 F1 · derivative.exercise_date: These options vest as follows: 15,000 shares on 7-23-2020; 15,000 shares vest on 7-23-2021 and 15,000 shares vest on 7-23-2022. Read SEC document |
| April 18, 2018 Filed Apr 19, 2018 17:14 UTC | ULTRALIFE CORP ULBI · Entity 6735 | GrantCommon Stock (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0001437749-18-007169 · rdgdoc.xml · derivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2025-04-18 F1 · derivative.exercise_date: These options vest as follows: 13,334 shares on 4-18-2019; 13,333 shares vest on 4-18-2020 and 13,333 shares vest on 4-18-2021. Read SEC document |
| November 04, 2016 Filed Nov 4, 2016 20:05 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 3,801 | $4.20 | $15,964.20 |
DisclosureSEC source: 0001437749-16-041146 · rdgdoc.xml · nonDerivative · entry 4 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,288 Read SEC document |
| November 03, 2016 Filed Nov 4, 2016 20:05 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 3,900 | $4.10 | $15,978.30 |
DisclosureSEC source: 0001437749-16-041146 · rdgdoc.xml · nonDerivative · entry 3 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,487 Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 1,899 | $4.10 | $7,785.90 |
DisclosureSEC source: 0001437749-16-041146 · rdgdoc.xml · nonDerivative · entry 2 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,587 Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC | ULTRALIFE CORP ULBI · Entity 6735 | PurchaseCommon Stock; $.10 par value | 400 | $4.15 | $1,660.00 |
DisclosureSEC source: 0001437749-16-041146 · rdgdoc.xml · nonDerivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,688 Read SEC document |
| June 07, 2011 Filed Apr 21, 2017 17:32 UTC Amendment | ULTRALIFE CORP ULBI · Entity 6735 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $6.42 | $0.00 |
DisclosureSEC source: 0001437749-17-006942 · rdgdoc.xml · derivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock; $.10 par value · 250,000 shares Expires 2020-12-30 F1 · derivative.expiration_date: On April 19, 2017, our Board of Directors, on recommendation of the Compensation and Management Committee, extended the option expiration date from December 30, 2017 to December 30, 2020, pursuant to the Company's Amended and Restated 2004 Long-Term Incentive Plan. Read SEC document |
| June 07, 2011 Filed Jul 27, 2018 20:02 UTC Amendment | ULTRALIFE CORP ULBI · Entity 6735 | GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001437749-18-013900 · rdgdoc.xml · derivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock; $.10 par value · 200,000 shares Expires 2020-12-30 F1 · derivative.exercise_date: Per Form 4 filed on June 7, 2011 and as amended on August 29, 2011, vesting for this option was to begin on the date the Company's Common Stock first reaches a closing price of $10.00 for 15 trading days in a 30 trading-day period, with such vesting in equal amounts of 50,000 shares over the four anniversary dates of such date. On July 25, 2018 our Board of Directors, on recommendation of the Compensation and Management Committee and pursuant to the Company's Amended and Restated 2004 Long-Term Incentive Plan, modified this option such that it will fully vest immediately upon the Company's Common Stock first reaching a closing price of $10.00 for 15 trading days in a 30 trading-day period. Read SEC document |
| December 30, 2010 Filed Apr 21, 2017 17:29 UTC Amendment | ULTRALIFE CORP ULBI · Entity 6735 | GrantCommon Stock; $.10 par value · Derivative | 50,000 | $0.00 Strike: $6.42 | $0.00 |
DisclosureSEC source: 0001437749-17-006941 · rdgdoc.xml · derivative · entry 1 POPIELEC MICHAEL D · CIK 0001226859 · Director · Director, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock; $.10 par value · 50,000 shares Expires 2020-12-30 F1 · derivative.expiration_date: On April 19, 2017, our Board of Directors, on recommendation of the Compensation and Management Committee, extended the option expiration date from December 30, 2017 to December 30, 2020, pursuant to the Company's Amended and Restated 2004 Long-Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.